Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HOWARD J RUBENSTEIN

Allopathic & Osteopathic Physicians Family Medicine

NPI
1376598086
CMS profile
244149
Location
SARALAND, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$792.39

63 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $792.39 63

By paying entity

PY2020 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 63 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HOWARD J RUBENSTEIN

NPI 1376598086 · CMS profile ID 244149

Allopathic & Osteopathic Physicians / Family Medicine

SARALAND, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 63 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1376598086?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 63 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1376598086?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 63 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1376598086?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
HOWARD J RUBENSTEIN, NPI 1376598086, CMS profile ID 244149, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 63 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1376598086?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

63 matching records · $792.39 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 63 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 63.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Lilly USA, LLC $20.8712/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728440043 CMS
Novo Nordisk Inc $15.6512/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745053659 CMS
Lilly USA, LLC $8.5412/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728456797 CMS
Merck Sharp & Dohme Corporation $11.8212/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747827685 CMS
Lilly USA, LLC $15.5711/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728456795 CMS
Eisai Inc. $16.5011/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751233703 CMS
Novo Nordisk Inc $17.4811/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744983465 CMS
PFIZER INC. $12.6111/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743795111 CMS
Novo Nordisk Inc $15.5810/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744998677 CMS
Merck Sharp & Dohme Corporation $13.6610/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747784055 CMS
Lilly USA, LLC $14.8410/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728463721 CMS
Lilly USA, LLC $4.4910/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728446721 CMS
Novo Nordisk Inc $12.3010/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744916979 CMS
Lilly USA, LLC $6.2309/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728460191 CMS
PFIZER INC. $12.5409/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743775625 CMS
Allergan, Inc. $13.2809/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723542133 CMS
PFIZER INC. $17.0008/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743378919 CMS
Novo Nordisk Inc $14.4108/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744848463 CMS
Lilly USA, LLC $16.8708/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728443375 CMS
Eisai Inc. $16.5008/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751221599 CMS
Lilly USA, LLC $16.8808/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728463725 CMS
Novo Nordisk Inc $16.6608/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745021909 CMS
Horizon Therapeutics plc $12.5707/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721438061 CMS
PFIZER INC. $13.7207/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743292619 CMS
Allergan, Inc. $14.7807/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723542131 CMS
Lilly USA, LLC $20.6307/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728453471 CMS
Antares Pharma, Inc. $14.9407/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751420293 CMS
Novo Nordisk Inc $2.2007/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744770187 CMS
PFIZER INC. $15.2806/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743735955 CMS
Merck Sharp & Dohme Corporation $13.5606/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747633603 CMS
Eisai Inc. $15.4406/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751345103 CMS
AstraZeneca Pharmaceuticals LP $13.3406/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736267281 CMS
Teva Pharmaceuticals USA, Inc. $15.1606/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749513809 CMS
Amgen Inc. $15.9806/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741084199 CMS
GlaxoSmithKline, LLC. $14.4805/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738600247 CMS
Allergan, Inc. $11.3305/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723542129 CMS
PFIZER INC. $14.3105/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743419151 CMS
Novo Nordisk Inc $15.3105/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744688069 CMS
Daiichi Sankyo Inc. $17.7805/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739487945 CMS
PFIZER INC. $7.2205/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743721287 CMS
Amarin Pharma Inc. $20.9105/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740002309 CMS
Amgen Inc. $15.5605/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741084197 CMS
GlaxoSmithKline, LLC. $15.3803/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738811657 CMS
Novo Nordisk Inc $1.5203/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744736845 CMS
Novo Nordisk Inc $4.1103/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744736849 CMS
Amgen Inc. $20.1903/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741084203 CMS
AstraZeneca Pharmaceuticals LP $12.9203/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736094443 CMS
Novo Nordisk Inc $1.9402/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744627151 CMS
Novo Nordisk Inc $0.2702/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744627169 CMS
Merck Sharp & Dohme Corporation $11.2602/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747667049 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,704.05 108
PY2020 $792.39 63
PY2021 $1,250.93 61
PY2022 $1,424.94 82
PY2023 $2,008.26 62
PY2025 $1,028.79 6

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $290,410.38 20
PY2024 Principal investigator $582,175.45 67
PY2023 Principal investigator $178,596.47 28
PY2022 Principal investigator $323,131.01 30
PY2021 Principal investigator $410,276.56 30
PY2020 Recipient $1,694.65 7
PY2020 Principal investigator $897,181.33 26
PY2019 Principal investigator $623,481.03 21

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

21 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 CIPLA USA INC. $300.00 11/27/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712619
Principal investigator 1 CIPLA USA INC. $7,127.90 11/12/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712707
Principal investigator 1 CIPLA USA INC. $3,950.00 11/12/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712709
Principal investigator 1 CIPLA USA INC. $3,007.22 10/31/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694717047
Principal investigator 1 CIPLA USA INC. $20.00 10/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS - RESEARCH
U-FS-MU-AS3120 No dispute reported 06/30/2026 694710301
Principal investigator 1 CIPLA USA INC. $24.00 10/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS - RESEARCH
U-FS-MU-AS3120 No dispute reported 06/30/2026 694712729
Principal investigator 1 PFIZER INC. $158,610.84 10/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671665745
Principal investigator 1 CIPLA USA INC. $7,200.67 07/25/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694711813
Principal investigator 1 CIPLA USA INC. $16.80 07/23/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS - RESEARCH
U-FS-MU-AS3120 No dispute reported 06/30/2026 694714843
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $27.44 07/11/2019 Non-covered Recipient Entity
THE CTR FOR CLINICAL TRIALS INC
Exercise capacity study in HFpEF No dispute reported 06/30/2026 704143379
Principal investigator 1 CIPLA USA INC. $160.55 06/18/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
U-FS-MU-AS3120 No dispute reported 06/30/2026 694718023
Principal investigator 1 PFIZER INC. $7,075.00 06/17/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671622799
Principal investigator 1 PFIZER INC. $25,116.83 06/03/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671622783
Principal investigator 1 AstraZeneca UK Limited $3,997.00 05/20/2019 Non-covered Recipient Entity
Elias Research Associates Llc
A 26 Week Multicenter Randomized Placebo Controlled Double Blind Parallel Group Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg and Saxagliptin 2.5 and 5 mg in Pediatric Patients with Type 2 Diabetes Mellitus who are between 10 and below 18 years of age No dispute reported 06/30/2026 685000063
Principal investigator 1 PFIZER INC. $7,100.00 04/30/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671622797
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $283,588.06 04/10/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED, PARALLEL-GROUP TRIAL EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF CENTANAFADINE SUSTAINED-RELEASE TABLETS IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER TRIAL 405-201-00013 No dispute reported 06/30/2026 696053981
Principal investigator 1 Otsuka Pharmaceutical Development & Commercialization, Inc. $68,936.35 04/10/2019 Non-covered Recipient Entity
ELIAS RESEARCH ASSOCIATES LLC
AN OPEN-LABEL, 52-WEEK, MULTICENTER TRIAL EVALUATING THE LONG-TERM SAFETY AND TOLERABILITY OF CENTANAFADINE SUSTAINED-RELEASE TABLETS IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER No dispute reported 06/30/2026 696053995
Principal investigator 1 PFIZER INC. $48.00 02/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671637795
Principal investigator 1 PFIZER INC. $2,395.90 01/03/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671695415
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $44,730.47 01/02/2019 Non-covered Recipient Entity
Elias Research Associates LLC
Exercise capacity study in HFrEF No dispute reported 06/30/2026 704143421
Principal investigator 1 PFIZER INC. $48.00 01/01/2019 Non-covered Recipient Entity
THE CENTER FOR CLINICAL TRIALS
A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO AND ACTIVECONTROLLED MULTICENTER PARALLELGROUP STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN ADULT SUBJECTS WITH CHRONIC LOW BACK PAIN No dispute reported 06/30/2026 671637793